Thus, attenuation of TRPA1 and TRPV1 expression and their surface trafficking, plus inhibition of itch-related neuropeptide release from pruritic nerve would underlie the observed anti-pruritic activity of BoNTs in animal models of chronic itch and in patients with itch conditions (171, 174). The gene discussed is TRPA1; the disease is Pruritus.